KRAS-G12C-INHIBITOREN

European patent · EP3844151 · Deleted

Register entry

Publication number
EP3844151
Application number
EP19855183
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Aug 29, 2019
Published
Jul 7, 2021
Granted
Aug 23, 2023
Deleted
Mar 23, 2024
Reason
Annual fee unpaid
IPC classes
C07D 487/04 (2006.01)
A61K 31/519 (2006.01)
A61P 35/00 (2006.01)
Priority
US 201862725449 P 31.08.2018
PCT application
PCT/US2019/048713 29.08.2019
PCT publication
WO2020/047192 05.03.2020
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 3, 2024

    Change

    Published in Swissreg on 03.07.2024

  2. Apr 26, 2024

    Publication

    Published in Swissreg on 26.04.2024

  3. Apr 24, 2024

    Change

    Published in Swissreg on 24.04.2024

  4. Apr 17, 2024

    Owner

    Owner
    Array BioPharma Inc., 3200 Walnut Street, Boulder, CO 80301, USA, Mirati Therapeutics, Inc., 9393 Towne Centre Drive, Suite 200, San Diego, CA 92121, USA → Array BioPharma Inc., 3200 Walnut Street, Boulder, CO 80301, USA, Mirati Therapeutics, Inc., 3545 Cray Court, San Diego, CA 92121, USA

    Published in Swissreg on 17.04.2024

  5. Mar 23, 2024

    Deleted, fee unpaid

    Published in Swissreg on 23.03.2024

  6. Aug 23, 2023

    Granted

    Published in Swissreg on 23.08.2023

Parties

Inventor

FELL, Jay, Bradford

Boulder, CO 80301, US

MEJIA, Macedonio, J.

Boulder, CO 80301, US

MARX, Matthew, Arnold

San Diego, CA 92127, US

FISCHER, John, P.

Boulder, CO 80301, US

BLAKE, James, F.

Boulder, CO 80301, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.